Showing 2871-2880 of 21408 results for "".
- Enhancing Home Care Safety: The Impact of Visual Mapping Tools on Quality of Lifehttps://reachmd.com/news/enhancing-home-care-safety-the-impact-of-visual-mapping-tools-on-quality-of-life/2471660/Amidst the evolving healthcare landscape, utilizing visual mapping tools within electronic medical records stands as a pivotal technique to bolster patient safety, particularly for the elderly and at-risk patients receiving home care. The integr
- The Link Between Heart Defects and Childhood Cancer: New Insightshttps://reachmd.com/news/the-link-between-heart-defects-and-childhood-cancer-new-insights/2471667/Recent research confirms that infants born with congenital heart defects (CHD) are at an elevated risk for childhood cancer, highlighting essential considerations for pediatric and maternal healthcare strategies.
- Defining the Diagnostic Frontier: Unraveling Topical Steroid Withdrawal and Its Biochemical Underpinningshttps://reachmd.com/news/defining-the-diagnostic-frontier-unraveling-topical-steroid-withdrawal-and-its-biochemical-underpinnings/2471673/At the forefront of dermatological research, the National Institutes of Health (NIH) has established precise diagnostic criteria for topical steroid withdrawal (TSW), distinctly separating it from eczema. This study highlights that elevated levels of NAD+ are a crucial fact
- Exploring the Link Between Dietary Intakes and Pregnancy Complications Through Mendelian Randomizationhttps://reachmd.com/news/exploring-the-link-between-dietary-intakes-and-pregnancy-complications-through-mendelian-randomization/2471654/New Insights into Maternal Health: Unraveling the Genetic and Nutritional Nexus Recent advances using Mendelian randomization illuminate how dietary factors affect pregnancy outcomes, presenting promising opportunities to enhance maternal care.
- Reevaluating Adjuvant Therapy: Insights from the NRG Oncology GOG-0263 Trial in Early-Stage Cervical Cancerhttps://reachmd.com/news/reevaluating-adjuvant-therapy-insights-from-the-nrg-oncology-gog-0263-trial-in-early-stage-cervical-cancer/2471663/Reassessing Combined Treatment: The Trial That Questions Adjuvant Chemoradiotherapy's Role The NRG Oncology GOG-0263 phase III trial challenges the assumption that combining cisplatin-based chemotherapy with adjuvant radiotherapy after surgery
- Innovative Surgical Approaches to Restore Smell in Long COVID Patientshttps://reachmd.com/news/innovative-surgical-approaches-to-restore-smell-in-long-covid-patients/2471656/Exploring Nasal Surgery as a Beacon of Hope for Long COVID Sufferers Innovative surgical techniques using nasal passage surgery are emerging as a promising solution to restore the sense of smell in Long COVID patients, offering new hope for improved quality of life
- Exploring Muscle Diseases: The Intersection of Metabolic, Endocrine, and Rheumatologic Insightshttps://reachmd.com/news/exploring-muscle-diseases-the-intersection-of-metabolic-endocrine-and-rheumatologic-insights/2471615/The diagnostic process for muscle diseases often relies on the specialized expertise of rheumatologists. Their role is to integrate comprehensive clinical evaluations, laborato
- Enhancing Maternal Health: The Role of Education, ICTs, and Economic Empowermenthttps://reachmd.com/news/enhancing-maternal-health-the-role-of-education-icts-and-economic-empowerment/2471620/Maternal health remains a critical indicator of a nation’s well-being. By integrating women’s education, ICT innovations, and improved income levels, significant strides can be made in reducing maternal mortality and achieving sustainable health outcom
- 2025 AAD: Physosocial Implications of Neuromodulator Injectionshttps://reachmd.com/news/2025-aad-physosocial-implications-of-neuromodulator-injections/2473760/The “Botulinum Toxins: The Latest Updates” session at the 2025 American Academy of Dermatology (AAD) Annual Meeting concluded with Vince Bertucci, MD, FAAD, discussing the topic of “Physosocial Implications of Neuromodulator Injections.” Dr. Bertucci explained the facial feedbac
- Interim Analysis: Dupilumab Reduces Itch, Pain in Ichthyosis and EBhttps://reachmd.com/news/Interim-Analysis-Dupilumab-Reduces-Itch-Pain-Ichthyosis-EB/2471652/Dupilumab reduced both itch and pain in congenital ichthyosis and epidermolysis bullosa (EB), with no new safety issues, in an interim analysis presented during the late-breakers sessions at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida. Medical student